title: Cognitive-adaptive disabilities.
abstract: Cognitive-adaptive disabilities (CADs) are not frequently seen in the general pediatric setting. Yet, given the high rates of comorbidity in that population, they commonly demand a lot of time and effort on the part of clinicians. One aspect of comorbidity is the degree to which psychiatric disorders occur in children, adolescents, and young adults with CADs. This article reviews the epidemiology, associated psychopathology, and pharmacologic treatment of selected CADs.
authors.affiliation: Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA. calles@kcms.msu.edu
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Calles
mesh_terms: D000293:Adolescent; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D003072:Cognition Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D015897:Comorbidity; D002658:Developmental Disabilities / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D004062:DiGeorge Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D004314:Down Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D005600:Fragile X Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D006801:Humans; D008297:Male; D009456:Neurofibromatosis 1 / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D011247:Pregnancy; D014402:Tuberous Sclerosis / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology